Related Experiment Video
Updated: Mar 29, 2026

09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
8.9K
Genetics of Behçet's disease.
Laura T Morton1, Deva Situnayake, Graham R Wallace
1University of Birmingham, Edgbaston, Birmingham, UK.
Current Opinion in Rheumatology
|November 25, 2015
Summary
Recent genetic and epigenetic findings illuminate Behçet's disease pathogenesis. Understanding these changes, including human leukocyte antigen-B and cytokine alterations, offers new therapeutic targets.
Area of Science:
- Immunogenetics
- Molecular Biology
- Pathogenesis Research
Background:
- Behçet's disease is a complex inflammatory disorder with poorly understood genetic and epigenetic underpinnings.
- Previous research identified associations with human leukocyte antigen-B (HLA-B) and dysregulated cytokine production.
Purpose of the Study:
- To review recent genetic and epigenetic associations implicated in the pathogenesis of Behçet's disease.
- To highlight emerging molecular pathways and potential therapeutic targets.
Main Methods:
- Review of recent genetic association studies, including genome-wide association studies (GWAS).
- Analysis of epigenetic modifications such as DNA methylation and microRNA expression.
- Integration of findings related to immune cell function and inflammatory pathways.
Main Results:
- Strong association confirmed between HLA-B and Behçet's disease.
- Polymorphisms in Toll-like receptors (TLR) and FUT2 suggest microbiome involvement.
- Single nucleotide polymorphisms in chemokine and adhesion molecules are linked to vascular damage.
- Altered expression of microRNAs (miR155, miR21, miR23b) and DNA methylation changes in immune cells observed.
Conclusions:
- Genetic and epigenetic alterations provide novel insights into Behçet's disease mechanisms.
- These changes identify potential therapeutic targets, including cytoskeletal protein function.
- Further research may address ethnic variations in genetic associations and disease presentation.
Related Concept Videos
Genetic Lingo
117.7K
Overview
117.7K
Pedigree Analysis
90.8K
Overview
90.8K
Genome-wide Association Studies-GWAS
16.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.6K
Incomplete Dominance
32.5K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.5K
Cohesins
5.9K
Cohesin protein complexes are a molecular glue that holds two sister chromatids together. They play an important role both in mitosis and meiosis. In mitosis, all cohesin complexes present on the chromosomes are removed before the start of the anaphase stage.
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
5.9K
Pharmacogenomics: Identification of New Drug Targets
76
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76

